Study for Participants With Relapsed/Refractory Non-Hodgkin Lymphoma
Clinical trial NCT06334991 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06334991
- Sponsor
- ImmunityBio, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-23
- Primary completion
- 2027-10-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.